Skip to main content

Sun Anthony Y's Form 4 filing

Zentalis Pharmaceuticals, Inc. (ZNTL) · filed Dec 2, 2021

Accession no.
0001725160-21-000232
Filed
Dec 2, 2021
Trade date
Nov 26-Dec 2, 2021
Filing delay
6 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 17 non-derivative transactions. Open-market sales total $1.62M. It was filed 6 days after the trade, past the 2-business-day deadline.

This filing was later replaced by the amendment 0001725160-21-000236 (Dec 7, 2021). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sun Anthony YCIK 0001377952Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 26, 2021Common StockGGiftDisposed−125,000$0.00$01,124,601Direct
Nov 26, 2021Common StockGGiftAcquired+125,000$0.00$0125,000Indirect
Dec 1, 2021Common StockSSaleDisposed−1,548$73.36F3−$113,561.281,123,053Direct
Dec 1, 2021Common StockSSaleDisposed−921$74.23F4−$68,365.831,122,132Direct
Dec 1, 2021Common StockSSaleDisposed−800$75.85F5−$60,6801,121,332Direct
Dec 1, 2021Common StockSSaleDisposed−500$77.09F6−$38,5451,120,832Direct
Dec 1, 2021Common StockSSaleDisposed−396$78.59F7−$31,121.641,120,436Direct
Dec 1, 2021Common StockSSaleDisposed−3,502$79.65F8−$278,934.31,116,934Direct
Dec 1, 2021Common StockSSaleDisposed−2,700$80.32F9−$216,8641,114,234Direct
Dec 1, 2021Common StockSSaleDisposed−104$81.12−$8,436.481,114,130Direct
Dec 2, 2021Common StockSSaleDisposed−311$72.76F10−$22,628.361,113,819Direct
Dec 2, 2021Common StockSSaleDisposed−1,289$73.62F11−$94,896.181,112,530Direct
Dec 2, 2021Common StockSSaleDisposed−600$74.68F12−$44,8081,111,930Direct
Dec 2, 2021Common StockSSaleDisposed−500$75.99F13−$37,9951,111,430Direct
Dec 2, 2021Common StockSSaleDisposed−3,824$77.36F14−$295,824.641,107,606Direct
Dec 2, 2021Common StockSSaleDisposed−3,823$77.97F15−$298,079.311,103,783Direct
Dec 2, 2021Common StockSSaleDisposed−124$78.85F16−$9,777.41,103,659Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.91 to $73.90. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F4

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.91 to $74.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F5

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.34 to $76.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F6

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.81 to $77.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F7

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.07 to $79.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F8

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.10 to $80.08. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F9

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.11 to $80.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F10

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.12 to $73.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F11

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.23 to $74.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F12

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $74.45 to $75.29. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F13

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.62 to $76.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F14

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.72 to $77.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F15

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.74 to $78.40. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

F16

The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.77 to $79.18. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)